Morgan Stanley Maintains Overweight on Laboratory Corp, Lowers Price Target to $260
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Overweight rating on Laboratory Corp (NYSE:LH) but lowers the price target from $285 to $260.
August 04, 2023 | 1:42 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Overweight rating on Laboratory Corp but lowers the price target from $285 to $260.
The news is directly about Laboratory Corp and is likely to impact its stock. While the Overweight rating is positive, the lowering of the price target might have a neutral to slightly negative impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100